ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 55

Adipose Derived Stem Cell Suppressed Synovial Inflammation and Repaired Cartilage Destruction in Rheumatoid Arthritis Model Mice

Tadashi Okano1, Kentaro Inui2, Hideki Ueyama3, Kumi Orita3, Tatsuya Koike4 and Hiroaki Nakamura2, 1Orthopedic Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan, 2Orthopaedic Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan, 3Osaka City University Graduate School of Medicine, Osaka, Japan, 4Center for Senile Degenerative Disorders, Osaka City University Graduate School of Medicine, Osaka, Japan

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: adipose tissue, Animal models, animal models and stem cells, cartilage, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 21, 2018

Title: Rheumatoid Arthritis – Animal Models Poster

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Adipose derived stem cell (ADSC) is one of the stem cells produced by adipose tissue which can be collected easily and in large quantities. It has been reported the anti-inflammatory effect of ADSC in some disease models. However, the effect of ADSC for synovitis such as rheumatoid arthritis (RA) is unknown. The aim of this study is to investigate the effects of ADSC for intraarticular synovitis and cartilage degeneration in SKG/Jcl mice in vivo and the effects of ADSC for synovial fibroblast in vitro.

Methods: SKG/Jcl mice which developed auto-immune arthritis by adjuvant stimulation were used as RA animal model. In vivo, the intra-articular injections of ADSC or PBS were performed to the bilateral knee of SKG mice with arthritis. The knee joint was histologically assessed with synovitis score and Mankin score at week 2 after ADSC injection. In vitro, the anti-inflammatory effect of ADSC for stimulated human synovial fibroblast was analyzed by real-time RT-PCR.

Results: In vivo, the synovitis score and Mankin score were significantly lower in ADSC group (synovitis score 2.0 } 0.7 vs 6.0 } 1.6, p<0.01 and Mankin score 2.2 } 0.8 vs 4.9 } 0.8, p<0.01) (Figure 1). Surprisingly, the cartilage degeneration was repaired in ADSC group (Figure 2). As a comparison, glucocorticoid injection suppressed the synovial inflammation but cartilage degeneration was not improved (Figure 2). In vitro, the expression of tumor necrosis factor-stimulated gene-6 (TSG-6), the anti-inflammatory cytokine, was significantly higher in ADSC than in synovial cell (p<0.01). The inflammatory cytokine levels in stimulated synovial cell were significantly decreased by ADSC treatment (p<0.01).

Figure 1. The anti-inflammatory effects of intra-articular ADSC injection.

The H-E stain of knee joint in SKG/Jcl mice (a) and PBS treated SKG/Jcl mice after induction of synovitis (b). The synovial proliferation was suppressed in ADSC treated SKG/Jcl mice after induction of synovitis (c). The Safranin-O stain in SKG/Jcl mice without synovitis (d), PBS treated SKG/Jcl mice (e) and ADSC treated SKG/Jcl mice (f) after induction of synovitis. The cartilage staining was reduced in SKG/Jcl mice with inflammatory synovitis (yellow arrows).

Figure 2. Cartilage repair in ADSC group

Conclusion: This is the first report to show the anti-inflammatory effect of ADSC for synovitis in RA animal model. ADSC can be collected with a minimally invasive technique more easily than other mesenchymal stem cells. ADSC might have potential to be one of the RA treatment and repair cartilage degeneration.


Disclosure: T. Okano, None; K. Inui, None; H. Ueyama, None; K. Orita, None; T. Koike, None; H. Nakamura, None.

To cite this abstract in AMA style:

Okano T, Inui K, Ueyama H, Orita K, Koike T, Nakamura H. Adipose Derived Stem Cell Suppressed Synovial Inflammation and Repaired Cartilage Destruction in Rheumatoid Arthritis Model Mice [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/adipose-derived-stem-cell-suppressed-synovial-inflammation-and-repaired-cartilage-destruction-in-rheumatoid-arthritis-model-mice/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/adipose-derived-stem-cell-suppressed-synovial-inflammation-and-repaired-cartilage-destruction-in-rheumatoid-arthritis-model-mice/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology